[Management of cutaneous risk in pharmacovigilance: metabolic predisposition to Stevens-Johnson syndromes and toxic epidermal necrolysis].
Wolkenstein
P
P
Service de Dermatologie, Hôpital Henri-Mondor, Créteil, France.
D000927:Anticonvulsants / Q000009:adverse effects*; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D012307:Risk Factors; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced* / Q000209:etiology* / Q000378:metabolism; D013449:Sulfonamides / Q000009:adverse effects*
D000927:Anticonvulsants; D013449:Sulfonamides